相关实验视频
Updated: Jan 11, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
通过调节ERK激活,OX-40信号促进CTCL中的瘤形成
Evangelia Papadavid1, Fani Karagianni1, Eleni-Kyriaki Vetsika2
1National Center of Rare Diseases-Cutaneous Lymphoma, Second Department of Dermatology and Venereal Diseases, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
OX-40通路通过促进转移和M2巨细胞积累来驱动皮肤T细胞淋巴瘤 (CTCL) 的进展. 向OX-40可能为CTCL提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 皮肤T细胞淋巴瘤 (CTCL) 涉及通过细胞因子或免疫突触激活T细胞,如OX-40/OX-40L相互作用.
- 在Mycosis fungoides/Sézary综合征中,OX-40和OX-40L共同表达,与疾病严重程度相关.
研究的目的:
- 研究OX-40在CTCL转移中的功能作用及其作为治疗点的潜力.
- 评估OX-40对瘤微环境 (TME) 和与巨细胞的相互作用的影响.
主要方法:
- 利用CRISPR-Cas9在胚胎自发转移模型中产生OX-40淘汰CTCL细胞.
- 评估瘤生长,扩散,TME调节 (包括巨细胞),超内皮迁移,血管生成和淋巴血管生成.
主要成果:
- OX-40的表达增强了血管内,转移,细胞因子分泌和M2巨的招募.
- 在M2巨细胞中,OX-40促进了超内皮细胞的迁移和传播,可能是通过ERK激活.
- OX-40通过VEGF-C表达刺激了淋巴血管生成,但没有影响血管生成.
结论:
- OX-40显著调节CTCL中的TME,促进M2巨细胞,淋巴细胞生成和转移.
- 小胚胎转移模型是CTCL研究的宝贵临床前工具.
- OX-40轴是CTCL进展的关键驱动因素,突出了其作为治疗点的潜力.
更多相关视频
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal